Semapimod is an inhibitor of proinflammatory cytokine production, suppressing TNF-α, IL-1β, and IL-6; it inhibits macrophage p38 MAPK activation and nitric oxide production; it blocks TLR4 signaling (IC50 ≈ 0.3 μM); and has potential therapeutic applications in various inflammatory and autoimmune diseases.